Our study confirms that FRAT1 provides vital functions in GSCs, which provides new insights into the role of FRAT1 in tumor progression and reinforces the relevance of FRAT1 and GSCs as viable therapeutic targets for glioma. This evidence concerns the gene FRAT1 and glioma.